2009
DOI: 10.1152/ajpcell.00492.2008
|View full text |Cite
|
Sign up to set email alerts
|

Histone H3 as a novel substrate for MAP kinase phosphatase-1

Abstract: Kinney CM, Chandrasekharan UM, Yang L, Shen J, Kinter M, McDermott MS, DiCorleto PE. Histone H3 as a novel substrate for MAP kinase phosphatase-1. Am J Physiol Cell Physiol 296: C242-C249, 2009. First published November 19, 2008 doi:10.1152/ajpcell.00492.2008.-Mitogen-activated protein (MAP) kinase phosphatase-1 (MKP-1) is a nuclear, dual-specificity phosphatase that has been shown to dephosphorylate MAP kinases. We used a "substrate-trap" technique involving a mutation in MKP-1 of the catalytically critical … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
29
0

Year Published

2009
2009
2019
2019

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 39 publications
(32 citation statements)
references
References 60 publications
3
29
0
Order By: Relevance
“…These findings are in agreement with another study in keratinocytes, showing that DMF inhibited MSK-1 phosphorylation at Ser376 independently of p38 or ERK MAPK [21]. MKP-1, an endogenous inhibitor of MAPK, can be upregulated by reduced GSH levels [29] and, besides inhibiting MAPK p38 and ERK in ASMCs [23], it was reported to dephosphorylate histone H3 at Ser10 [30]. However, DMF treatment did not affect MKP-1 level in our study, suggesting that it does not mediate the inhibitory effect of DMF on histone H3 phosphorylation.…”
Section: Discussionsupporting
confidence: 91%
“…These findings are in agreement with another study in keratinocytes, showing that DMF inhibited MSK-1 phosphorylation at Ser376 independently of p38 or ERK MAPK [21]. MKP-1, an endogenous inhibitor of MAPK, can be upregulated by reduced GSH levels [29] and, besides inhibiting MAPK p38 and ERK in ASMCs [23], it was reported to dephosphorylate histone H3 at Ser10 [30]. However, DMF treatment did not affect MKP-1 level in our study, suggesting that it does not mediate the inhibitory effect of DMF on histone H3 phosphorylation.…”
Section: Discussionsupporting
confidence: 91%
“…9C versus Fig. 5C), increased MKP-1 activity could be responsible for the subsequent decrease in Ser10 phosphorylation either by dephosphorylating MAP kinases or histone H3-Ser10 itself (Kinney et al, 2009). Alternatively, the change in Ser10 phosphorylation may be regulating the transcription of MKP-1 (Li et al, 2001).…”
Section: Discussionmentioning
confidence: 93%
“…MKP-1 is a negative regulator of MAP kinase, hence a decrease in MAP kinase activity will result from induction of MKP-1 (Clark, 2003;Kuwano et al, 2008). In addition, MKP-1 can directly dephosphorylate P-H3-Ser10 in vitro (Kinney et al, 2009). However, in this model there was no induction of MKP-1 mRNA at the 5-g dose (Fig.…”
Section: Discussionmentioning
confidence: 99%
“…For example, Aurora kinases A and B have been demonstrated to catalyze the addition of phosphate groups at H3S10, whereas mitogen-activated protein (MAP) kinase phosphatase-1 has previously been shown to promote the enzymatic removal of phosphate groups at this residue (Pascreau et al, 2003;Kinney et al, 2009). In brain, the dopamine and cAMP regulated protein phosphatase inhibitor, DARPP-32, as well as the MAP kinase, MSK1, provide excellent examples of enzymes regulating H3S10p in response to environmental stimuli, indicating histone phosphorylation as an important regulator of adult neuronal function (Brami-Cherrier et al, 2005;Stipanovich et al, 2008).…”
Section: Histone Phosphorylation and Cross Talk Interactions In The Cnsmentioning
confidence: 99%